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Abstract 
Background: During cardiopulmonary bypass, oxidative stress happens in the 
patient's cells due to blood contact with various levels of synthetic materials. It 
can activate inflammatory process and release factors such as interleukin 6 (IL-
6), C reactive protein (CRP) and neutrophilia, which may hurt different organs. 
In recent years, many efforts have been made to prevent this type of damage; 
however, no single treatment has been proposed to reduce this risk. Antioxidant 
substances such as Thiamine is important in cell defense against free oxygen 
radicals. Regarding this issue, in this study, effect of Thiamine on lactate levels 
in patients undergoing coronary artery bypass graft (CABG) surgery has been 
investigated. 
Methods and materials: In this study, 140 patients, 25 to 65 years with mild 
systolic dysfunction (EF=45-55%) who were candidates for elective CABG 
surgery in two groups, control and purpose (patients receiving Thiamine), were 
examined. All of these patients anesthetized in an identical manner, and 
subjected to a heart-lung pump. Serum lactate levels were measured before, 
during and six, 12, 18, 24 hours after surgery. All data collected in a 
questionnaire recorded and evaluated using SPSS statistical software. 
Results: Study groups showed no significant differences regarding 
demographics and underlying diseases. Serum lactate was significantly lower 
in Thiamine group during the first 24 hours after surgery (except before 
operation and 2 hours later) (p <0.05). Creatinine level in two groups before 
surgery was not significantly difference, however, it was significantly lower in case group 24 hours after surgery 
(1.54±0.14 vs. 1.24±0.19; p: 0.001). In addition, dose of Inotropes in patients who received Thiamine, was 
significantly lower than the control group (p= 0.001). Extubation was longer in control group (15.4±4.9 vs. 
13.15±4.1; p=0.003) while intensive care unit stay was not different.  
Conclusion: It seems that Thiamine administration before cardiopulmonary bypass in patients with decreased left 
ventricular function could decrease serum lactate as tissue perfusion marker and improve kidney function.  
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Introduction 
During cardiopulmonary bypass (CPB) surgery, 
inflammatory responses occur for various reasons 
(surgical stress, ischemic reperfusion injury, gas micro 
embolic and particulate) that cause functional 
impairment in vital organs such as the heart, lungs and 
kidneys (1). In an accurate statement, it should be 
noted that stress of surgery leads to inflammatory 
reactions. However, using CPB exacerbates these 
inflammatory responses due to increased blood contact 
with external surfaces (2). These inflammatory 
responses cause oxidative stress, which is usually 
associated with the release of inflammatory factors 
such as C reactive protein (CRP), interleukin 6 (IL-6) 
and neutrophilia (3). Thus, complications of oxidative 
stress, by disturbing the balance between free radicals 
and antioxidants, could exacerbate complications in 
cardiopulmonary bypass (4). All of these cases indicate 
that use of antioxidant substances can help to balance 
effects of increased oxidative stress in patients 
undergoing cardiopulmonary bypass surgery. 
One of the most important markers for 
improving index of tissue perfusion is serum lactate, 
which increases during CPB and it is more significant 
in patients with systolic dysfunction (5). Antioxidant 
substances such as Thiamine and Glutathione in a form 
of remission (GSH) have a high degree of cellular 
defense against oxygen free radicals (6). Thiamine 
(vitamin B1) have antioxidant effects, and with an 
unknown mechanism, can improve tissue perfusion 
and thus improve the index of tissue perfusion, the 
serum lactate (7). Despite its extracellular function, 
glutathione plays an important role in purifications of 
free radicals. High level of GSH reduces loss of oxygen 
radicals during reperfusion (8). Intracellular GSH is 
made up of Glycine and Glutamate amino acids and 
Cysteine containing Thiol (9).  
In recent years, many efforts have been made to 
reduce the damage to organs following 
cardiopulmonary bypass surgery. Due to spread of 
different sciences and techniques, there is still no 
specific method for reducing immunological 
complications and inflammatory effects of this type of 
surgery. However, it seems that prescribing 
antioxidants and drugs during CPB can resolve this 
problem. 
Considering that in patients undergoing 
cardiopulmonary bypass surgery, serum Thiamine 
levels are reduced and there has not been any specific 
research on effects of thiamine administration on heart 
function and lactate levels; the research team decided 
to investigate its effect on serum lactate levels in 
patients undergoing cardiopulmonary bypass surgery. 
Methods 
This study designed as a clinical trial and 
registered in the Iranian clinical trial registry with this 
code: IRCT2016051412642N24 (dual blinded). 
Initially, 140 patients with mild heart failure who were 
selected for coronary artery bypass graft (CABG) 
surgery (by obtaining consent and the criteria" Aged 25 
to 65 years, candidate for elective CABG surgery, mild 
heart failure (EF between 45% and 55%), thiamine 
insensitivity, lack of brain problems and lack of post-
surgical infections entered the study phase. These 
patients divided to two groups with 70 participants. At 
all stage’s patients divided between two groups 
randomly. Two groups including; screening group 
(300 mg thiamine in 100 ml normal saline 0.9% before 
CPB) and control group (100 ml normal saline 0.9% 
before CPB). All patients received a same 
premedication group (1 mg of lorazepam (P0)) 2 hours 
and (Morphine 0.1 mg/kg/intramuscular) an hour 
before surgery. For induction of anesthesia used from 
Fentanyl, Propofol and Atracurium. Infused Propofol, 
Fentanyl and Atracurium to maintain anesthesia. 
Surgery performed using standard on-pump method 
and patients transferred to the intensive care unit (ICU) 
intubated and later weaned from ventilator according 
to standard protocol. 
In all patients, serum Lactate levels measured 
before, during and after surgery (2, 4, 6, 12, 18 and 24 
hours after surgery). All data collected in a 
questionnaire and evaluated using SPSS statistical 
software (T-test used to compare parametric variables, 
Mann-Whitney U test, Chi-square tests and Fisher 
exact test used to compare non-parametric variables in 
two groups). 
Results 
The most patients in the study were men and 
male to female ratio was 63.7% to 36.3% in the control 
group and 65.5% to 34.5% in the case one. Results of 
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this study showed that there was no significant 
difference between two groups regarding age, sex, 
height and weight. In addition, according to Table 1, 
factors such as body surface area (BSA), ejection 
fraction (EF) and the American society of 
anesthesiologists (ASA) class had no statistically 
significant difference (P>0.05). 
Table 2 compares underlying diseases in two 
study groups. Results indicated the meaningless 
relationship between patients in mentioned groups 
regarding these issues. 
Serum lactate surveyed in patients (before 
surgery and during 24 hours after surgery) showed a 
statistically significant difference between two groups 
(except before and 2 hours after surgery) and this factor 
was significantly lower in the treatment group than the 
control group (Table 3). 
Results showed that creatinine level in two 
groups before surgery was not significantly different. 
However, there was a significant difference in serum 
creatinine, 24 hours after surgery (p<0.05). Table four 
shows mechanical ventilation time after surgery had a 
Table 1: Demographic variables, ASA class, and Ejection fraction of patients in two groups. 
 Control (n=70) Thiamine (n=70) P-value 
Age (year) 56.3±10.2 58.4±9.4 0.25 
Height (cm) 167.3±11.4 164.5±12.0 0.33 
Weight (Kg) 72.3±15.8 70.1±17.3 0.17 
BSA (m2) 1.6±0.16 1.7±0.21 0.39 
preoperative EF 
(%) 
45.9±7.3 44.8±6.6 0.48 
ASA Class (I/II) 24/46 22/48 0.11 
Sex 
(male/female) 
63.7%/36.3 65.5%/34.5% 0.32 
EF: Ejection Fraction. ASA: American Society of Anesthesiologists 
Table 2: Underlying diseases in two groups of patients. 
 Control (n=70) Thiamine (n=70) P-value 
Diabetes 36(52%) 30(42.5%) 0.22 
Hypertension 41 (58.6%) 43 (62.5%) 0.56 
Hyperlipidemia 19 (27%) 16 (23%) 0.31 
Cigarette 
smoking 
12 (17%) 16 (23%) 0.19 
MI 1(1.4%) 1(1.4%) - 
CVA 1(1.4%) 0 - 
MI: myocardial Infarction, CVA: Cerebrovascular Accident 
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significant difference in two groups, but duration of 
ICU stays in two groups did not show any significant 
difference. 
Based on observations made on patients, there 
Table 3: Postoperative serums lactate in two groups of study. 
Lactate Control (n=70) Thiamine (n=70) P-value 
Before operation 
(mmol/L) 
2.54±0.67 2.63±0.73 0.34 
After 2h in ICU 2.25±0.79 2.61±1.7 0.23 
After 4h in ICU 3.55±0.64 2.49±0.33 0.001 
After 6h in ICU 2.82±0.34 2.28±0.43 0.001 
After 12h in ICU 2.29±0.44 2.06±0.41 0.0062 
After 18h in ICU 1.96±0.36 1.75±1.25 0.013 
After 24h in ICU 1.68±0.61 1.36±0.62 0.032 
MV: mechanical ventilation, ICU: Intensive Care Unit 
Table 4: Postoperative Base excess (BE) in two groups of study. 
 Control (n=70) Thiamine (n=70) P-value 
Creatinine 
Preoperative (mg/dL) 










Duration of MV (hours) 15.4±4.9 13.15±4.1 0.003 
Duration of ICU stay (days) 3.73±0.98 3.47±0.93 0.22 
MV: mechanical ventilation, ICU: Intensive Care Unit 
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were no significant differences in both groups 
regarding central venous pressure (CVP) during the 
first 24 hours after ICU admission and the data from 
these two groups was very close (p>0.05). Although 
base excess (BE) level was higher in the thiamine 
recipient group, however, except at 24 hours after 
Table 5: Postoperative Base excess (BE) in two groups of study 
BE (mEq/L) Control (n=70) Thiamine (n=70) P-value 
At entry to ICU -2.42±2.9 -2.42±2.46 0.99 
After 2h in ICU -3.05±2.2 -3.4±2.65 0.42 
After 4h in ICU -3.8±2.22 -3.41±3.12 0.51 
After 6h in ICU -3.56±2.1 -3.2±2.28 0.50 
After 12h in ICU -2.4±1.99 -1.90±2.20 0.22 
After 18h in ICU -1.21±1.98 -0.78±2.52 0.38 
After 24h in ICU -0.77±2.84 0.45±2.29 0.032 
 
Table 6: Postoperative vasopressor uses in two groups of study 













Epinephrine dose (µ 
/min) 
10.5±1.2 5.46±1.34 0.001 
Epinephrine total usage 
(µg) 















9.7±1.12 4.5±0.98 0.001 
Dopamine total usage 
(µg) 
288.5±34.6 112.2±26.6 0.001 
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surgery, no significant difference observed (Table 5). 
Regarding the percentage of patients who 
received epinephrine and dopamine during and after 
separation from the CPB and in ICU, there was no 
significant difference between the two groups (p> 
0.05). It should be noted that in patients under 
screening of thiamine, the dose of these two drugs was 
significantly lower than the control group (p< 0.005) 
(Table 6). 
Discussion 
Inflammation and accumulation of 
inflammatory factors, such as cytokines, associated 
with decreased renal function and increased serum 
lactate, are common in cardiopulmonary bypass 
surgery (10). Important factors for starting and 
continuing inflammation following CPB are not 
exactly specified. With the onset of inflammation, a 
large number of inflammatory factors and cells are 
activated. In the case of CPB, expression of cytokines 
and inflammatory factors such as endotoxins, tumor 
necrosis factors (TNFs), Antrodia cinnamomea 
fruiting bodies (NAKFB) and anaphylatoxins are 
increased (11). These agents release oxygen-free 
radicals and proteases by stimulating inflammatory 
cells, including polymorphonuclear 
neutrophils (PMN), platelets, and endothelial cells. 
Inflammation and release of free oxygen radicals 
followed by tissue damage (12). 
Different methods have been proposed to reduce 
inflammation. Reducing contact time with emergency 
cardiac care (ECC) (such as off-
pump coronary artery bypass (OPCAB) without 
pump) is one of the ways to reduce inflammation. Of 
course, along with this method, other methods (such as 
managing bleeding during surgery, less aortic 
manipulation in patients with atherosclerosis, using 
ultrafiltration, reducing prime volume, reducing the 
CPB duration, using heparin to cover the inner surfaces 
of tubes and filtering Selection of leukocytes from 
circulation) are used (13). 
About CPB, we could say that cause of 
increased lactate during cardiac surgery is the 
reduction of tissue perfusion and low pressure during 
the pump (11). Mainly, CPB reduces perfusion and 
reperfusion, however, with the exception of lactate; 
there are no diagnostic molecular markers for ischemic 
reperfusion injury. Increased lactate (>3) has proven to 
be a prognostic factor of mortality in open-heart 
surgery (14). Results of this study, showed that serum 
lactate (as a tissue perfusion index) in treatment group 
in comparison to control group decreased significantly 
(24 hours after surgery) (p<0.05). These results can be 
important to improvement of patients’ condition 
following the CPB. Reducing free radicals will lead to 
increased success in surgery outcome and accelerate 
patient recovery. Thus, based on results, thiamine may 
play a role in reducing complications and improving 
the efficiency of patients undergoing cardiopulmonary 
bypass surgery. However, the effectiveness of thiamine 
on cardiac factors and its performance has been proven 
in previous studies. For example, DiNicolantonio and 
colleagues in 2013 showed that use of thiamine 
supplements could improve heart function (15). 
Results of another study, performed by Luger et al. 
showed that lactate levels were significantly decreased 
in thiamin-treated patients (48 hours before surgery) 
(16). Our research results indicate that thiamine 
reduced creatinine levels. In this case, results are 
contradictory. For example, in previous studies, it 
demonstrated that thiamine did not significantly affect 
acute renal failure (ARF) reduction in patients under 
CPB (15, 16) and these findings confirmed by Wang et 
al. (17). However, in the present study only creatinine 
levels was examined (as a kidney function index). 
Overall, this decrease in serum levels could be 
attributed to controlling oxidative and inflammatory 
factors in the kidneys (18). 
In this study, inotropic drug used in thiamine-
screened patients was lower than the control group 
based on Lukienko et al. study. They stated that these 
results could be linked to the antioxidant properties of 
thiamine and lower level of lactate in treated group, 
which can cause better cardiovascular function (19). 
Meanwhile and based on Maddali and colleagues’ 
observations in 2006, that less inotropic use has 
provided conditions for reducing the patient's 
extubating time (20) whereas these results are also 
observed in our study. 
This study has been accompanied by limitations 
such as inability to measure serum thiamine levels in 
our country and no assessment of other kidney function 
markers, which can be addressed more precisely by 
fixing them. 
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Conclusion 
Use of thiamine before cardiopulmonary bypass 
can decrease lactate serum level as a marker of 
reperfusion injury and serum creatinine as a factor for 
kidney function in patients who have decreased left 
ventricle function, but the effect of thiamine seems to 
be limited and higher doses may be needed to further 
compensate for this damage. 
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